Global gastric cancer testing market was valued at US $ XX Mn and expected to grow at 5.0% Compound Annual Growth Rate (CAGR) over 2018 to 2024.Market Outline: Gastric Cancer Testing Market
Cancer begins in the body when the cells in the body grow without any control. Cells present in any part of the body can develop cancer, which tend to spread to the other parts of the body. Gastric cancer is a type of cancer that starts in the stomach.
Market Dynamics: Gastric Cancer Testing Market
Increase in the prevalence of gastrointestinal tumors, adenocarcinoma, lymphoma etc. and change in the lifestyles are majorly driving the growth of the gastric cancer testing market.
Free sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Market Scope: Gastric Cancer Testing Market
Gastric cancer testing market is segmented based on the test, product, gastric cancer type and end user.
Based on the test, the market is segmented into the following:
• Immunohistochemistry (IHC)
• Fluorescent in situ hybridization (FISH)
Based on the product, the market is segmented into the following:
• Kits
• Reagents
Based on the gastric cancer type, the market is segmented into the following:
• Adenocarcinoma
• Lymphoma
• Gastrointestinal stromal tumor (GIST)
• Carcinoid tumor
Based on the end user, the market is segmented into the following:
• Hospitals
• Diagnostic centers
• Others
Free TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/#ulp-c654SbFYO64MsOhu[/URL]
Regional Analysis: Gastric Cancer Testing Market
Geographically, global gastric cancer testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia Pacific gastric cancer testing market is the dominant market when compared with that of the other regional markets. According to the World Cancer Research Fund International, Japan has held the largest share of around 24.7% in the global stomach cancer treatment market owing to its higher consumption of the spicy and salty food.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Competition Assessment: Gastric Cancer Testing Market
Some of the players in the global gastric cancer testing market include:
• Agilent Technologies, Inc. (U.S.)
• Thermo Fisher Scientific, Inc. (U.S.)
• Illumina, Inc. (Denmark)
• Becton, Dickinson and Company (U.S.)
• GE Healthcare (U.K.)
• QIAGEN N.V. (Netherlands)
Notable Market Developments: Gastric Cancer Testing Market
? In June 2016, Oxford Gene Technology (OGT) has launched extensive catalogue of fluorescence in situ hybridisation (FISH) products with 9 new Cytocell Aquarius probes which includes ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua and Chromosome 15 Alpha Satellite Probe Red.
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/[/URL]